Downregulation of TS, DPD, ERCC1, GST-Pi, EGFR, and HER2 gene expression after neoadjuvant three-modality treatment in patients with esophageal cancer
Keywords: CDDP; cisplatin; DPD; dihydropyrimidine dehydrogenase; EGFR; epidermal growth factor receptor; ERCC1; excision-repair cross-complementing factor 1; GST-Pi; glutathione S-transferase Pi [Ï]; HER2; human epidermal growth factor receptor 2; MAP; mitogen-act